• Home
  • About Us
  • Subscribe
  • Advertise
  • Newsroom
  • Sign In
  • Create Account
  • Sign Out
  • My Account
  • Current Issue
    • Latest News
    • Special Report
    • Up Close
    • Opinion
  • News by Sector
    • Real Estate & Construction
    • Banking & Finance
    • Health Care
    • Education & Talent
    • North Idaho
    • Technology
    • Manufacturing
    • Retail
    • Government
  • Roundups & Features
    • Calendar
    • People
    • Business Licenses
    • Q&A Profiles
    • Cranes & Elevators
    • Retrospective
    • Insights
    • Restaurants & Retail
  • Supplements & Magazines
    • Book of Lists
    • Building the INW
    • Market Fact Book
    • Economic Forecast
    • Best Places to Work
    • Partner Publications
  • E-Edition
  • Journal Events
    • Elevating the Conversation
    • Workforce Summit
    • Icons
    • Women in Leadership
    • Rising Stars
    • Best Places to Work
    • People of Influence
    • Business of the Year Awards
  • Podcasts
  • Sponsored
  • INW Senior
Home » Latest News » Cholesterol, diabetes prescriptions lead drug spending for the elderly

Cholesterol, diabetes prescriptions lead drug spending for the elderly

May 6, 2010
News Wise

Purchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007, equating to about one-fourth of the approximately $82 billion spent for medications for the elderly, says the federal Agency for Healthcare Research and Quality (AHRQ).

Metabolic drugs, which are used to lower cholesterol levels, to keep diabetes under control, and to address weight and thyroid problems, topped the list of the five leading categories of drugs purchased by the elderly. The analysis by the federal agency found that the other four drug classes in the top five in 2007 were:

•Cardiovascular drugs, including blood pressure medicines, diuretics, and drugs to control abnormal heart rhythms, such as atrial fibrillation, at $15 billion.

•Central nervous system drugs, such as arthritis and other pain medications, $8 billion.

•Gastrointestinal drugs, which include antacid medications, $7 billion.

•Hormones, to treat osteoporosis, cancer, and other conditions, $5 billion.

The focus of AHRQ, which is part of the U.S. Department of Health and Human Services, is to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. The data were reported in an AHRQ News and Numbers summary taken from the Medical Expenditure Panel Survey (MEPS), a detailed source of information on the health services used by Americans, the frequency with which they are used, the cost of those services, and how they are paid.

    Latest News
    • Related Articles

      Hospital units for elderly found to reduce expenses

      Drug found to help lower risk of some ailments for women

      Statins can do more than cut cholesterol

    News Wise

    Mayo Clinic seeks to dispel myths about ovarian cancer

    More from this author

    Stay Informed. It’s Free.

    Subscribe to our newsletters and get the latest news and insights delivered to your inbox.

    Choose the newsletters you’d like to receive:
    Please select at least one newsletter.

    We respect your privacy.
    Unsubscribe anytime.

    Thank you!

    You’re subscribed. Keep an eye on your inbox for the latest updates.

    Featured Poll

    What is the single biggest barrier to breaking ground on new projects in our region right now?

    Popular Articles

    • Stevemacdonald pullquote web
      By Karina Elias

      New Markets pipeline grows in Spokane

    • By Matt Stephens

      Voters' view of Spokane region holds steady

    • Mckinley %2821%29 web
      By Karina Elias

      Former McKinley School property listed for $3M

    • Stancraft jet center hanger d6 rendering web
      By Karina Elias

      A $3.5M hangar is underway at StanCraft Jet Center

    • Rivet3 web
      By Matt Stephens

      Commercial muralist builds brand identity, value

    • News Content
      • News
      • Special Report
      • Up Close
      • Roundups & Features
      • Opinion
    • More Content
      • E-Edition
      • E-Mail Newsletters
      • Newsroom
      • Special Publications
      • Partner Publications
    • Customer Service
      • Editorial Calendar
      • Our Readers
      • Advertising
      • Subscriptions
      • Media Kit
    • Other Links
      • About Us
      • Contact Us
      • Journal Events
      • Privacy Policy
      • Tri-Cities Publications

    Journal of Business BBB Business Review allianceLogo.jpg CVC_Logo-1_small.jpg

    All content copyright ©  2026 by the Journal of Business and Northwest Business Press Inc. All rights reserved.

    Design, CMS, Hosting & Web Development :: ePublishing